LINC01852 and colorectal carcinoma: In addition, these findings were further validated in an independent CRC cohort (73 NCTs and 85 CRC tissues), in which LINC01852 was downregulated in 71.2% (52/73) of the CRC tissues compared to the paired NCTs (Fig. 1C).